diclorofenac epolamine (Virpax/MedPharm)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namediclorofenac epolamine (Virpax/MedPharm)
Drug Alias NameEpoladermDSF-100OSF-200
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainMusculoskeletal PainOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirpax Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedPharm LtdVirpax Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPainMusculoskeletal PainOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A